Terms: = Lung cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
35 results:
1. D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC.
Hu H; Chen WJ; Sun C; Xie JP
Medicine (Baltimore); 2023 Nov; 102(45):e34877. PubMed ID: 37960828
[TBL] [Abstract] [Full Text] [Related]
2. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
3. Patient specific evaluation of breathing motion induced interplay effects.
Varasteh M; Ali A; Esteve S; Jeevanandam P; Göpfert F; Irvine DM; Hounsell AR; McGarry CK
Phys Med; 2023 Jan; 105():102501. PubMed ID: 36529007
[TBL] [Abstract] [Full Text] [Related]
4. nbn Pathogenic Germline Variants are Associated with Pan-cancer Susceptibility and In Vitro DNA Damage Response Defects.
Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
[TBL] [Abstract] [Full Text] [Related]
5. Anti-EGF nanobodies enhance the antitumoral effect of osimertinib and overcome resistance in non-small cell lung cancer (NSCLC) cellular models.
Guardiola S; Sánchez-Navarro M; Rosell R; Giralt E; Codony-Servat J
Med Oncol; 2022 Sep; 39(12):195. PubMed ID: 36071367
[TBL] [Abstract] [Full Text] [Related]
6. DNA repair and immune checkpoint blockade response.
Guo JA; Alshalalfa M; Kim DY; Hoffman HI; Shiau C; Su J; Hwang WL; Mahal BA
Cancer Genet; 2022 Jun; 264-265():1-4. PubMed ID: 35245846
[TBL] [Abstract] [Full Text] [Related]
7. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
de Bono JS; Mehra N; Scagliotti GV; Castro E; Dorff T; Stirling A; Stenzl A; Fleming MT; Higano CS; Saad F; Buttigliero C; van Oort IM; Laird AD; Mata M; Chen HC; Healy CG; Czibere A; Fizazi K
Lancet Oncol; 2021 Sep; 22(9):1250-1264. PubMed ID: 34388386
[TBL] [Abstract] [Full Text] [Related]
8. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
Li H; Ma L; Bian X; Lv Y; Lin W
Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic depletion of CCR8
Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
[TBL] [Abstract] [Full Text] [Related]
10. [Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.].
Soto Parra HJ; Noto L; Aiello MM
Recenti Prog Med; 2020 Dec; 111(12):58e-62e. PubMed ID: 33362184
[TBL] [Abstract] [Full Text] [Related]
11. BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell lung cancer Cells.
Fiorentino FP; Marchesi I; Schröder C; Schmidt R; Yokota J; Bagella L
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339368
[TBL] [Abstract] [Full Text] [Related]
12. Nijmegen Breakage Syndrome Complicated With Primary Pulmonary Granulomas.
Marczak H; Heropolitańska-Pliszka E; Langfort R; Roik D; Grzela K
Pediatrics; 2018 Oct; 142(4):. PubMed ID: 30209074
[TBL] [Abstract] [Full Text] [Related]
13. Minimizing dose variation from the interplay effect in stereotactic radiation therapy using volumetric modulated arc therapy for lung cancer.
Kubo K; Monzen H; Tamura M; Hirata M; Ishii K; Okada W; Nakahara R; Kishimoto S; Kawamorita R; Nishimura Y
J Appl Clin Med Phys; 2018 Mar; 19(2):121-127. PubMed ID: 29368420
[TBL] [Abstract] [Full Text] [Related]
14. Suppression of Sirt1 sensitizes lung cancer cells to WEE1 inhibitor MK-1775-induced DNA damage and apoptosis.
Chen G; Zhang B; Xu H; Sun Y; Shi Y; Luo Y; Jia H; Wang F
Oncogene; 2017 Dec; 36(50):6863-6872. PubMed ID: 28869605
[TBL] [Abstract] [Full Text] [Related]
15. Network based stratification of major cancers by integrating somatic mutation and gene expression data.
He Z; Zhang J; Yuan X; Liu Z; Liu B; Tuo S; Liu Y
PLoS One; 2017; 12(5):e0177662. PubMed ID: 28520777
[TBL] [Abstract] [Full Text] [Related]
16. Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.
Broos K; Keyaerts M; Lecocq Q; Renmans D; Nguyen T; Escors D; Liston A; Raes G; Breckpot K; Devoogdt N
Oncotarget; 2017 Jun; 8(26):41932-41946. PubMed ID: 28410210
[TBL] [Abstract] [Full Text] [Related]
17. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract] [Full Text] [Related]
18. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
[TBL] [Abstract] [Full Text] [Related]
19. Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-lung Metastatic Model.
Tonsing-Carter E; Bailey BJ; Saadatzadeh MR; Ding J; Wang H; Sinn AL; Peterman KM; Spragins TK; Silver JM; Sprouse AA; Georgiadis TM; Gunter TZ; Long EC; Minto RE; Marchal CC; Batuello CN; Safa AR; Hanenberg H; Territo PR; Sandusky GE; Mayo LD; Eischen CM; Shannon HE; Pollok KE
Mol Cancer Ther; 2015 Dec; 14(12):2850-63. PubMed ID: 26494859
[TBL] [Abstract] [Full Text] [Related]
20. Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes.
Zhong X; Yang H; Zhao S; Shyr Y; Li B
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S7. PubMed ID: 26099277
[TBL] [Abstract] [Full Text] [Related]
[Next]
